Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

> Different dementia rating scales may give different results because the study is underpowered for the effect, and/or Aducanumab is only effective in a subset of patients.

Though if a couple thousand people is underpowered for the effect, that's not a great sign for the drug.



Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: